%0 Journal Article %T Phosphorylated CCAAT/Enhancer Binding Protein ¦Â Contributes to Rat HIV-Related Neuropathic Pain: In Vitro and In Vivo Studies %A Ching-Hang Liu %A Daigo Ikegami %A David A. Lubarsky %A Hirotsugu Kanda %A Hyun Yi %A Keiya Takahashi %A Shuanglin Hao %A Shue Liu %A Takafumi Iida %A Wan Huang %A Yuta Kashiwagi %J The Journal of Neurosience %D 2018 %R 10.1523/JNEUROSCI.3647-16.2017 %X Chronic pain is increasingly recognized as an important comorbidity of HIV-infected patients, however, the exact molecular mechanisms of HIV-related pain are still elusive. CCAAT/enhancer binding proteins (C/EBPs) are expressed in various tissues, including the CNS. C/EBP¦Â, one of the C/EBPs, is involved in the progression of HIV/AIDS, but the exact role of C/EBP¦Â and its upstream factors are not clear in HIV pain state. Here, we used a neuropathic pain model of perineural HIV envelope glycoprotein gp120 application onto the rat sciatic nerve to test the role of phosphorylated C/EBP¦Â (pC/EBP¦Â) and its upstream pathway in the spinal cord dorsal horn (SCDH). HIV gp120 induced overexpression of pC/EBP¦Â in the ipsilateral SCDH compared with contralateral SCDH. Inhibition of C/EBP¦Â using siRNA against C/EBP¦Â reduced mechanical allodynia. HIV gp120 also increased TNF¦Á, TNFRI, mitochondrial superoxide (mtO2¡¤£¿), and pCREB in the ipsilateral SCDH. ChIP-qPCR assay showed that pCREB enrichment on the C/EBP¦Â gene promoter regions in rats with gp120 was higher than that in sham rats. Intrathecal TNF soluble receptor I (functionally blocking TNF¦Á bioactivity) or knockdown of TNFRI using antisense oligodeoxynucleotide against TNFRI reduced mechanical allodynia, and decreased mtO2¡¤£¿, pCREB and pC/EBP¦Â. Intrathecal Mito-tempol (a mitochondria-targeted O2¡¤£¿scavenger) reduced mechanical allodynia and decreased pCREB and pC/EBP¦Â. Knockdown of CREB with antisense oligodeoxynucleotide against CREB reduced mechanical allodynia and lowered pC/EBP¦Â. These results suggested that the pathway of TNF¦Á/TNFRI¨CmtO2¡¤£¿¨CpCREB triggers pC/EBP¦Â in the HIV gp120-induced neuropathic pain state. Furthermore, we confirmed the pathway using both cultured neurons treated with recombinant TNF¦Á in vitro and repeated intrathecal injection of recombinant TNF¦Á in naive rats. This finding provides new insights in the understanding of the HIV neuropathic pain mechanisms and treatment. SIGNIFICANCE STATEMENT Painful HIV-associated sensory neuropathy is a neurological complication of HIV infection. Phosphorylated C/EBP¦Â (pC/EBP¦Â) influences AIDS progression, but it is still not clear about the exact role of pC/EBP¦Â and the detailed upstream factors of pC/EBP¦Â in HIV-related pain. In a neuropathic pain model of perineural HIV gp120 application onto the sciatic nerve, we found that pC/EBP¦Â was triggered by TNF¦Á/TNFRI¨CmtO2¡¤£¿¨CpCREB signaling pathway. The pathway was confirmed by using cultured neurons treated with recombinant TNF¦Á in vitro , and by repeated intrathecal injection of recombinant TNF¦Á in naive %U http://www.jneurosci.org/content/38/3/555